Related references
Note: Only part of the references are listed.Assessing the efficacy of targeted therapy using circulating epithelial tumor cells (CETC): the example of SERM therapy monitoring as a unique tool to individualize therapy
Katharina Pachmann et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2011)
Effect of Occult Metastases on Survival in Node-Negative Breast Cancer
Donald L. Weaver et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Recurrence and mortality according to Estrogen Receptor status for breast cancer patients undergoing conservative surgery. Ipsilateral breast tumour recurrence dynamics provides clues for tumour biology within the residual breast
Romano Demicheli et al.
BMC CANCER (2010)
The Breast Cancer Alternative Hypothesis: Is There Evidence to Justify Replacing It?
Bernard Fisher et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Cell Cycle and Anti-Estrogen Effects Synergize to Regulate Cell Proliferation and ER Target Gene Expression
Mathieu Dalvai et al.
PLOS ONE (2010)
Hypothesis: primary antiangiogenic method proposed to treat early stage breast cancer
Michael W. Retsky et al.
BMC CANCER (2009)
T1N0 Triple Negative Breast Cancer: Risk of Recurrence and Adjuvant Chemotherapy
Henry G. Kaplan et al.
BREAST JOURNAL (2009)
Micrometastases or Isolated Tumor Cells and the Outcome of Breast Cancer
Maaike de Boer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
New Concepts in Breast Cancer Emerge from Analyzing Clinical Data Using Numerical Algorithms
Michael Retsky
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2009)
Metastasis: from dissemination to organ-specific colonization
Don X. Nguyen et al.
NATURE REVIEWS CANCER (2009)
The effects of surgery on tumor growth: a century of investigations
R. Demicheli et al.
ANNALS OF ONCOLOGY (2008)
Dormancy and surgery-driven escape from dormancy help explain some clinical features of breast cancer
M. W. Retsky et al.
APMIS (2008)
Vascularization in primary breast carcinomas: Its prognostic significance and relationship with tumor cell dissemination
Hari Prasad Dhakal et al.
CLINICAL CANCER RESEARCH (2008)
Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse
Katharina Pachmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
The relevance of circulating epithelial tumor cells (CETC) for therapy monitoring during neoadjuvant (primary systemic) chemotherapy in breast cancer
O. Camara et al.
ANNALS OF ONCOLOGY (2007)
Dormancy of solitary metastatic cells
Jason L. Townson et al.
CELL CYCLE (2006)
Longtime recirculating tumor cells in breast cancer patients
K Pachmann
CLINICAL CANCER RESEARCH (2005)
Maintenance therapy to suppress micrometastasis: The new challenge for adjuvant cancer treatment
RJ Epstein
CLINICAL CANCER RESEARCH (2005)
30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort study
G Bonadonna et al.
BRITISH MEDICAL JOURNAL (2005)
Standardized quantification of circulating peripheral tumor cells from lung and breast cancer
K Pachmann et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2005)
Circulating tumor cells in patients with breast cancer dormancy
SD Meng et al.
CLINICAL CANCER RESEARCH (2004)
Molecular biology of breast cancer metastasis - Clinical implications of experimental studies on metastatic inefficiency
AF Chambers et al.
BREAST CANCER RESEARCH (2000)
Share Paper
